Search research articles
Contact Us
Filters
Showing results (61-70 of 114) with videos related to
Page
of 12
Sort By:
Chemmedchem
|
November 26, 2008
Natural-product-like spiroketals and fused bicyclic acetals as potential therapeutic agents for B-cell chronic lymphocytic leukaemia
Lech-Gustav Milroy, Giovanna Zinzalla, François Loiseau, et al.
Frontiers in Oncology
|
June 19, 2023
NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma
Eleanor Jayawant, Arran Pack, Heather Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2009
Rel a is an independent biomarker of clinical outcome in chronic lymphocytic leukemia
Saman Hewamana, Thet Thet Lin, Clare Rowntree, et al.
British Journal of Haematology
|
November 20, 2008
Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia
Guy Pratt, Stephen Harding, Roger Holder, et al.
Blood and Lymphatic Cancer : Targets and Therapy
|
May 27, 2026
Exploring the Bone Marrow Microenvironment as a Therapeutic Barrier and Targetable Source of Crosstalk in Acute Myeloid Leukemia
Aleksandra Kolosova, Imogen Anna Mould, Chris Pepper, et al.
British Journal of Haematology
|
May 28, 2008
Highly purified CD38 sub-populations show no evidence of preferential clonal evolution despite having increased proliferative activity when compared with CD38 sub-populations derived from the same chronic lymphocytic leukaemia patient
Thet Thet Lin, Saman Hewamana, Rachel Ward, et al.
NPJ Systems Biology and Applications
|
June 6, 2023
Computational modeling of DLBCL predicts response to BH3-mimetics
Ielyaas Cloete, Victoria M Smith, Ross A Jackson, et al.
Oncogene
|
January 10, 2024
A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo
Hussein N Al-Ali, Scott J Crichton, Charlene Fabian, et al.
Journal of Medicinal Chemistry
|
January 29, 2019
Effects of Systematic Shortening of Noncovalent C8 Side Chain on the Cytotoxicity and NF-κB Inhibitory Capacity of Pyrrolobenzodiazepines (PBDs)
David B Corcoran, Thomas Lewis, Kazi S Nahar, et al.
Journal of Medicinal Chemistry
|
October 25, 2025
Design, Synthesis, and Biological Evaluation of Efflux-Resistant Imatinib Derivatives
Madiha M Chowdhury, Priantha Pretheshan, Nasima S Chowdhury, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 114) with videos related to
Sort By:
Page
of 12
Chemmedchem
|
November 26, 2008
Natural-product-like spiroketals and fused bicyclic acetals as potential therapeutic agents for B-cell chronic lymphocytic leukaemia
Lech-Gustav Milroy, Giovanna Zinzalla, François Loiseau, et al.
Frontiers in Oncology
|
June 19, 2023
NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma
Eleanor Jayawant, Arran Pack, Heather Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2009
Rel a is an independent biomarker of clinical outcome in chronic lymphocytic leukemia
Saman Hewamana, Thet Thet Lin, Clare Rowntree, et al.
British Journal of Haematology
|
November 20, 2008
Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia
Guy Pratt, Stephen Harding, Roger Holder, et al.
Blood and Lymphatic Cancer : Targets and Therapy
|
May 27, 2026
Exploring the Bone Marrow Microenvironment as a Therapeutic Barrier and Targetable Source of Crosstalk in Acute Myeloid Leukemia
Aleksandra Kolosova, Imogen Anna Mould, Chris Pepper, et al.
British Journal of Haematology
|
May 28, 2008
Highly purified CD38 sub-populations show no evidence of preferential clonal evolution despite having increased proliferative activity when compared with CD38 sub-populations derived from the same chronic lymphocytic leukaemia patient
Thet Thet Lin, Saman Hewamana, Rachel Ward, et al.
NPJ Systems Biology and Applications
|
June 6, 2023
Computational modeling of DLBCL predicts response to BH3-mimetics
Ielyaas Cloete, Victoria M Smith, Ross A Jackson, et al.
Oncogene
|
January 10, 2024
A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo
Hussein N Al-Ali, Scott J Crichton, Charlene Fabian, et al.
Journal of Medicinal Chemistry
|
January 29, 2019
Effects of Systematic Shortening of Noncovalent C8 Side Chain on the Cytotoxicity and NF-κB Inhibitory Capacity of Pyrrolobenzodiazepines (PBDs)
David B Corcoran, Thomas Lewis, Kazi S Nahar, et al.
Journal of Medicinal Chemistry
|
October 25, 2025
Design, Synthesis, and Biological Evaluation of Efflux-Resistant Imatinib Derivatives
Madiha M Chowdhury, Priantha Pretheshan, Nasima S Chowdhury, et al.
Page
of 12